Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
JCO Oncology Practice|July 5, 2023
Chimeric Antigen Receptor T-Cell Therapy for Hematologic Malignancies: A Practical ReviewPaolo Strati, Tara Gregory, Navneet S Majhail, et al.Cancers|March 14, 2026
Outpatient Versus Inpatient Administration of Ciltacabtagene Autoleucel in Multiple Myeloma: A Systematic Review of Clinical, Economic, and Humanistic OutcomesTara Gregory, Kevin C De Braganca, Victoria Alegria, et al.Blood Advances|March 27, 2026
Dexamethasone prophylaxis for excessive lymphocyte expansion after cilta-cel in multiple myelomaPeter A Forsberg, Jacqueline A Turner, Marita Meyer, et al.Blood Advances|October 17, 2024
Access barriers to anti-CD19+ CART therapy for NHL across a community transplant and cellular therapy networkMinoo Battiwalla, Michael Tees, Ian Flinn, et al.British Journal of Haematology|September 19, 2022
Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphomaFateeha Furqan, Kwang W Ahn, Yue Chen, et al.Blood|June 3, 2026
Arlocabtagene autoleucel-a GPRC5D-targeted CAR T-cell therapy in heavily pretreated relapsed/refractory multiple myelomaSusan Bal, Myo Htut, Omar Nadeem, et al.Transplantation and Cellular Therapy|March 23, 2025
Comparative Efficacy of Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion Before Chimeric Antigen Receptor T-Cell Therapy in LymphomaUttam K Rao, Navneet S Majhail, Betsy Blunk, et al.Transplantation and Cellular Therapy|March 20, 2022
ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Multiple MyelomaBinod Dhakal, Nina Shah, Ankit Kansagra, et al.Pageof 1